Interventions for Adolescent Obesity



Status:Completed
Conditions:Obesity Weight Loss
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:12 - 18
Updated:2/10/2019
Start Date:January 2017
End Date:November 2018

Use our guide to learn which trials are right for you!

The Role of Activity Tracking on Weight Loss in Obese Adolescents

This study will be the first to evaluate whether the short- and long-term use of activity
tracking devices improve short- and long-term weight loss in adolescents. The investigators
will be the first to establish whether weight loss translates into a change in
obesity-related biomarkers associated with adolescent obesity. In addition, the investigators
will be the first to report outcomes after the implementation of activity tracking devices in
conjunction with an intense adolescent weight loss program.

This study will evaluate the short- and long-term use of activity tracking devices and their
effects on short- and long-term weight loss in adolescents. The investigators plan to
establish whether weight loss translates into a change in obesity-related biomarkers
associated with adolescent obesity. Each participant with an activity tracking device will
have the goal of reaching 10,000 steps per day, in addition to their individual fitness plan.
Ten thousand steps per day is the current recommendation for improving health and decreasing
risk of heart disease. Ten thousand steps a day is also a rough equivalent of the US Surgeon
General's recommendation to accumulate 30 minutes of activity most days of the week. Activity
tracking devices will also monitor daily total body energy expenditure and mean sleep hours.

Inclusion Criteria:

1. Subject has provided informed consent in a manner approved by the IRB and is willing
and able to comply with the trial procedures.

2. At least 12 and younger than 18 years of age at the time of consent.

3. BMI ≥ 95th percentile for age and sex group or BMI ≥ 35 kg/m2

Exclusion Criteria:

1. Any medical condition that, in the opinion of the investigator, would place the
subject at increased risk for participation.

2. Use of an investigational agent in the 30 days prior to signing informed consent

3. History of prior non-compliance or the presence or history of psychiatric condition
(including drug or alcohol addiction) that would, in the opinion of the investigator,
make it difficult for the subject to comply with the study procedures or follow the
investigators instructions.

4. Females who are pregnant or lactating

5. Subjects taking medications that can potentially cause weight gain

6. Subjects unable to participate in the comprehensive weight loss program due to
pre-existing conditions (paralysis, heart failure, severe autism or mental
retardation, psychosis, etc.)

7. Prisoners
We found this trial at
1
site
301 University Blvd
Galveston, Texas 77555
(409) 772-1011
University of Texas Medical Branch Established in 1891 as the University of Texas Medical Department,...
?
mi
from
Galveston, TX
Click here to add this to my saved trials